Compagnie Lombard Odier S Cm A Idera Pharmaceuticals, Inc. Transaction History

Compagnie Lombard Odier S Cm A

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 13, 2019	SELL	$2.77 - $9.38 $38,087 - $128,975	-13,750 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$5.53 - $11.36 $76,037 - $156,200	13,750 New	13,750 $123,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.